Skip to contentSkip to Braille Studio

Library / Laws / 117th Congress / House Bills / H.R. 9011

H.R. 9011

To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish a process to allow the holders of abbreviated new drug applications to make labeling changes to include new or updated safety-related information, and for other purposes.

Print stageDateSize⠃
Introduced in House2022-09-281.9K⠃⠗⠋